Advances in Imaging and Diagnostics in Lung Disease: A Multimodal Approach

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Pulmonology".

Deadline for manuscript submissions: 30 September 2025 | Viewed by 309

Special Issue Editors


E-Mail Website
Guest Editor
Radiology and Medical Imaging University Clinic, ‘Victor Babes’ University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania
Interests: lung imaging; multimodal diagnostics; HRCT; hybrid imaging techniques; lung ultrasound

E-Mail Website
Guest Editor
Radiology and Medical Imaging University Clinic, ‘Victor Babes’ University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania
Interests: lung imaging; multimodal diagnostics; lung ultrasound; MRI diagnostics

Special Issue Information

Dear Colleagues,

Imaging techniques are critical for diagnosing and monitoring lung diseases, providing insights into disease processes, progression, and therapeutic outcomes. From high-resolution CT to MRI and ultrasound, these modalities have evolved to address unique challenges in pulmonary diagnostics. Multimodal imaging approaches now combine structural, functional, and molecular insights to advance the understanding of various lung diseases, including interstitial lung diseases, COPD, and infections such as COVID-19.

This Special Issue will focus on the latest advancements, challenges, and opportunities in lung imaging and diagnostics, as well as highlighting recent advancements in imaging technologies and their application to lung diseases. By covering a spectrum of modalities—including MRI, CT, ultrasound, and hybrid imaging techniques—this Special Issue will foster discussions about innovations in diagnostic accuracy, disease monitoring, and their impact on patient outcomes. Contributions aligning with these themes are encouraged to ensure a comprehensive exploration of this rapidly advancing field. We welcome original research articles and review papers in the following areas: multimodal imaging approaches in lung disease diagnosis; advances in MRI for functional and structural lung imaging; high-resolution computed tomography (HRCT) in interstitial lung diseases; the role of lung ultrasound (LUS) in bedside diagnostics and monitoring; hybrid imaging techniques (e.g., PET/CT and PET/MRI) in pulmonary medicine; artificial intelligence in lung imaging—from image acquisition to interpretation; comparative analyses of imaging modalities in specific lung conditions; novel imaging biomarkers for pulmonary diseases; and imaging in infectious lung diseases, including post-COVID complications. We invite submissions that discuss innovations, compare modalities, or focus on disease-specific imaging applications.

Dr. Diana Manolescu
Dr. Emil Robert Stoicescu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lung imaging
  • multimodal diagnostics
  • MRI
  • HRCT
  • lung ultrasound
  • pulmonary biomarkers
  • hybrid imaging
  • interstitial lung disease
  • AI in imaging
  • pulmonary medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 476 KiB  
Article
Assessment of the Abnormalities in Chest Computed Tomography and Pulmonary Function Test in Convalescents Six Months After COVID-19
by Katarzyna Guziejko, Anna Moniuszko-Malinowska, Robert Flisiak, Piotr Czupryna, Sebastian Sołomacha, Paweł Sowa, Marlena Dubatówka, Magda Łapińska, Łukasz Kiszkiel, Łukasz Szczerbiński, Piotr Paweł Laskowski, Maciej Alimowski, Gabriela Trojan and Karol Adam Kamiński
Medicina 2025, 61(5), 823; https://doi.org/10.3390/medicina61050823 - 29 Apr 2025
Viewed by 186
Abstract
Background: Despite the multiple waves of the COVID-19 pandemic, follow-up strategies for recovered patients remain inconclusive. This study aimed to evaluate chest computed tomography (CT) and pulmonary function test (PFT) abnormalities in convalescents six months after COVID-19 and to compare these findings with [...] Read more.
Background: Despite the multiple waves of the COVID-19 pandemic, follow-up strategies for recovered patients remain inconclusive. This study aimed to evaluate chest computed tomography (CT) and pulmonary function test (PFT) abnormalities in convalescents six months after COVID-19 and to compare these findings with those from a representative population cohort. The goal was to support more individualized pulmonary management of post-COVID-19 sequelae. Methods: This study population consisted of 2 groups: I—232 post-COVID-19 patients and II—543 patients from a population cohort. Chest CT was performed during the acute phase of COVID-19 and six months after. The PFTs were conducted six months after COVID-19. Results: There were no significant differences in FEV1, FVC, TLC, and DLCO in the two study groups. A singular GGO in 24 patients (20%), a crazy paving pattern in 1 patient (0.8%), thickening of interlobular septa in 4 patients (3.5%), consolidations in 4 patients (3.5%), traction bronchiectasis in 6 patients (5%), fibrosis in 6 patients (5%), and singular nodular densities in 68 patients (58%) were observed in chest CT 6 months after COVID-19. Most radiological abnormalities were clinically insignificant and did not require further diagnostic evaluation. No significant differences in chest CT and PFT six months after infection were observed between patients differing in the severity of inflammation during the acute disease or SARS-CoV-2 variant. Conclusions: The majority of chest CT abnormalities resolved within six months of recovery, regardless of SARS-CoV-2 variant or initial disease severity. Pulmonary function tests should be prioritized in post-COVID-19 follow-up, as PFT results in convalescents were comparable to those observed in the general population. Full article
Show Figures

Figure 1

Back to TopTop